Compare FMC Corp (FMC) vs Lufax Holding Ltd (LU) Price & Performance

FMC Corporation (FMC) trades at $10.72, down 1.74% on the day, reflecting ongoing challenges despite recent strategic moves. The stock shows a bearish technical trend with oversold RSI signals, while fundamentals reveal significant pressure with a net income margin of -72.93% and negative ROE of -80.78% for 2025. Recent developments include a $400 million minority investment from Tessenderlo Group and regulatory submission for new herbicide rimisoxafen, providing some operational support amid financial restructuring.

The outlook remains cautious with analyst consensus leaning neutral (50% Hold) despite a $16 price target suggesting 49% upside. Key risks include persistent revenue declines, high debt levels, and negative cash flow from operations. Investment opportunity exists if new product approvals and debt reduction efforts successfully stabilize profitability, but current financial metrics indicate substantial execution risk near term.

LU trades at $1.33, up 3.1% today, but technical indicators are bearish with moving averages signaling a downtrend. The company reported a net loss of $2.1 billion in 2025, with negative profit margins and returns. Multiple class-action lawsuits filed in May 2026 allege securities fraud, creating significant legal overhangs.

The outlook is challenged by persistent losses and legal risks, though low valuation ratios like P/S of 0.34 and P/B of 0.1 may attract value investors. Analyst consensus is moderately positive with 62% buy ratings, but investors face substantial downside risk from ongoing litigation and profitability concerns.